Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19019,152,2.18 [1.42-3.36],0.0003772966738856
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19994,205,1.68 [1.11-2.54],0.0136527773033475
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19761,1440,1.54 [1.32-1.80],4.859754364174608e-08
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Candidiasis,20009,452,1.56 [1.18-2.05],0.0018789891175919
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19353,3530,1.43 [1.29-1.58],1.2478575595587396e-11
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19328,3585,1.38 [1.24-1.52],6.838770268040685e-10
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19758,1185,1.30 [1.09-1.56],0.0036973260848783
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19922,110,1.66 [0.95-2.92],0.0762643622591468
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17642,1044,1.77 [1.48-2.12],4.788163545518492e-10
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17005,1263,1.83 [1.55-2.17],1.846635863526923e-12
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16653,272,1.80 [1.27-2.56],0.0010107525871028
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13056,2274,1.35 [1.18-1.54],7.854360695066273e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16602,404,2.01 [1.52-2.65],8.701778270941948e-07
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19974,1401,1.38 [1.18-1.63],9.963651652522784e-05
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Mycoses,20081,524,1.53 [1.18-1.98],0.0012835579056157
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19334,1013,1.45 [1.20-1.75],0.0001042990914951
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,20020,1153,1.79 [1.51-2.11],1.0210252188062548e-11
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18778,205,1.71 [1.13-2.58],0.0109605376336966
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20130,52,2.61 [1.34-5.06],0.0045598367640961
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19875,1008,1.76 [1.47-2.11],5.267064143256651e-10
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19876,64,1.87 [0.90-3.87],0.0913613599419847
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20074,114,2.24 [1.37-3.69],0.0014138210272958
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20059,99,2.21 [1.29-3.79],0.0037572069930118
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18714,393,2.25 [1.72-2.93],2.666078051500842e-09
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18578,257,1.88 [1.33-2.66],0.0003881571867703
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18675,102,2.22 [1.28-3.84],0.0044216016594538
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20115,48,2.33 [1.10-4.96],0.0277195113216045
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20069,154,1.02 [0.62-1.71],0.9253502079537156
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral warts,19965,50,1.39 [0.59-3.28],0.4507424381545866
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19987,72,1.02 [0.48-2.14],0.9648359983373136
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm,19878,229,0.69 [0.45-1.06],0.093695774642978
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20055,37,1.17 [0.42-3.26],0.7577274582089
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,20040,41,1.01 [0.38-2.70],0.985623337201624
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9518,71,0.79 [0.36-1.72],0.5548634482373684
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19729,1439,1.07 [0.91-1.27],0.4175382367785826
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of meninges,20116,58,1.30 [0.58-2.90],0.5275951834540019
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20050,72,0.81 [0.38-1.72],0.5771691197210461
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20106,104,0.88 [0.47-1.64],0.6872999150928896
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of ovary,10560,65,1.35 [0.64-2.85],0.4291838651357765
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Ascending colon,20095,386,0.96 [0.70-1.33],0.8182792118442859
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Caecum,20108,328,1.16 [0.82-1.64],0.3866905863384687
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",20002,76,2.33 [1.26-4.33],0.0071447685502014
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Descending colon,20093,223,0.89 [0.58-1.37],0.597497382740414
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Rectum,20049,351,0.95 [0.68-1.34],0.774068276044873
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19994,599,1.17 [0.90-1.50],0.2374020426747642
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Transverse colon,20086,457,1.11 [0.83-1.49],0.4890279261447934
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Carcinoma in situ of breast,7945,46,1.80 [0.74-4.40],0.1953478137631253
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7977,55,2.21 [1.01-4.83],0.0461937017171474
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14421,64,3.85 [2.36-6.30],6.994778054453827e-08
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14442,85,2.05 [1.14-3.69],0.0170718962208975
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20079,110,0.82 [0.45-1.52],0.537822072060292
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma, any site",20080,107,0.88 [0.48-1.64],0.6986083877370322
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Leiomyoma of uterus,10317,147,1.14 [0.68-1.91],0.6142967101032704
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Lung cancer and mesothelioma,12831,432,1.42 [1.09-1.86],0.0104489590641273
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Lymphoid leukaemia,14422,65,3.90 [2.40-6.35],4.2355273064061296e-08
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14549,192,1.18 [0.75-1.85],0.4736136244817991
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14621,264,1.56 [1.09-2.23],0.0154157623520594
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",8060,98,2.38 [1.37-4.12],0.0019844689348065
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14454,97,2.41 [1.43-4.08],0.0010320061906773
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14479,122,0.79 [0.44-1.42],0.4340429455714575
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14468,111,1.65 [0.95-2.89],0.0780196377032973
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",8042,80,1.84 [0.97-3.46],0.0601729045056499
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14465,108,0.64 [0.34-1.19],0.1554595182991078
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7224,829,0.96 [0.77-1.20],0.7241600326687503
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14475,118,1.07 [0.60-1.91],0.8140434354099595
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14439,82,1.17 [0.59-2.31],0.6587679918256986
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14478,121,1.18 [0.67-2.07],0.5777514472473126
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi,20003,162,1.03 [0.62-1.69],0.9218259418710716
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi of trunk,20106,68,0.68 [0.31-1.51],0.3464965658338245
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanoma in situ,14404,100,0.76 [0.40-1.46],0.4153417916563455
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14463,106,2.78 [1.78-4.33],6.342496002231268e-06
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14530,173,3.03 [2.18-4.20],3.061684316540919e-11
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14656,299,1.36 [0.96-1.92],0.0803041557773588
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14469,112,3.02 [2.02-4.52],6.750050320830119e-08
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Other benign neoplasms of skin,19980,147,0.80 [0.47-1.37],0.4226379057052644
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15628,1271,0.97 [0.81-1.16],0.7563122472892907
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15696,1339,0.99 [0.84-1.18],0.9542633820085292
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19868,330,2.02 [1.50-2.73],4.465599876719105e-06
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18182,111,2.79 [1.79-4.34],5.795566371804764e-06
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19598,60,1.49 [0.69-3.21],0.3118225865057158
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19504,2942,1.31 [1.17-1.47],3.5177369445249694e-06
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18700,60,0.78 [0.34-1.82],0.5681641977532654
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19733,58,2.72 [1.44-5.15],0.0020411428559821
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19716,1645,1.28 [1.10-1.49],0.0013090142530618
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19714,1643,1.28 [1.10-1.49],0.001407459040453
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18170,99,2.52 [1.54-4.11],0.0002217023573809
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19824,1184,1.51 [1.27-1.80],2.768288030104616e-06
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19778,103,1.41 [0.78-2.55],0.2593752104785766
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19598,60,2.45 [1.28-4.71],0.0071229793687464
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19609,71,1.20 [0.58-2.51],0.6226799595083583
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19970,295,1.72 [1.23-2.40],0.0014363352721891
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,20024,33,1.89 [0.69-5.16],0.2128053196308689
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19915,240,1.81 [1.25-2.60],0.0015133146101057
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18754,114,0.70 [0.38-1.28],0.2443669137678983
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13612,339,1.17 [0.83-1.64],0.3636759856207504
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18837,88,0.70 [0.35-1.43],0.327392273138711
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18842,93,0.63 [0.32-1.23],0.1747114035626873
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,13336,63,1.54 [0.72-3.29],0.2598543006701515
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18748,44,0.81 [0.31-2.12],0.6605769366780951
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18118,271,1.18 [0.81-1.72],0.3955076011581528
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19480,769,1.10 [0.88-1.38],0.4076805459376922
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19127,416,0.73 [0.53-1.01],0.0586709818299166
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18859,148,0.83 [0.49-1.41],0.4852185992637902
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19900,1196,1.02 [0.85-1.22],0.8403595289739125
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17038,1166,1.05 [0.87-1.26],0.5974658788761816
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",13344,71,1.35 [0.65-2.81],0.416406926800378
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",18193,86,0.85 [0.42-1.69],0.635793003175341
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13579,306,1.08 [0.75-1.55],0.6727273588291871
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,13322,49,2.35 [1.15-4.84],0.0197981419676845
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17196,3923,1.12 [1.01-1.24],0.0275015395099446
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13508,235,1.41 [0.95-2.10],0.0890135325701537
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13877,604,1.34 [1.04-1.72],0.0211293368547372
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20082,311,1.16 [0.81-1.65],0.4121439236258248
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19895,124,0.77 [0.43-1.38],0.3789787273305688
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13403,130,1.13 [0.65-1.97],0.6540692603910412
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",13342,69,2.58 [1.47-4.52],0.0009589513468644
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19582,1475,1.36 [1.16-1.60],0.000141661102885
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13592,319,1.66 [1.20-2.31],0.0023801805828665
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13604,331,1.59 [1.16-2.19],0.0044947230965535
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",14011,738,1.06 [0.84-1.34],0.6426301661876772
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13404,131,1.07 [0.61-1.85],0.8200005750912044
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19889,118,0.69 [0.38-1.26],0.2276926921673263
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,14037,764,1.65 [1.35-2.03],1.4825494780624557e-06
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13828,555,1.69 [1.32-2.16],3.177795567253712e-05
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17908,61,1.86 [0.90-3.83],0.094164518987061
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18787,5514,1.22 [1.12-1.32],3.548805793040308e-06
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,18157,50,1.52 [0.66-3.51],0.3276381564368334
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,18153,46,0.55 [0.21-1.46],0.2304685215014641
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19982,1591,1.05 [0.90-1.23],0.5099531361631144
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19980,1589,1.05 [0.90-1.23],0.5096705909153194
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,18162,55,1.59 [0.72-3.52],0.254692394984799
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19825,978,1.01 [0.83-1.24],0.8913330028406677
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15152,1879,1.49 [1.30-1.71],9.454534690768912e-09
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20119,253,1.35 [0.92-1.98],0.1226478819815861
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18809,98,1.24 [0.67-2.32],0.4920461825182998
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18950,103,0.93 [0.50-1.75],0.831550904505494
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18990,143,1.15 [0.68-1.95],0.6007107756584633
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13439,166,1.56 [0.98-2.49],0.0614023654917859
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17735,159,1.47 [0.91-2.35],0.1128828031350936
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2140,84,1.42 [0.74-2.69],0.2899066271992802
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2278,254,0.86 [0.58-1.27],0.4502469140273148
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17647,71,2.98 [1.67-5.31],0.0002250459427069
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2106,51,1.34 [0.58-3.08],0.4949677456515805
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19425,1849,1.50 [1.30-1.72],1.2176770097703604e-08
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19219,508,0.98 [0.74-1.29],0.863067831900977
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18219,372,1.22 [0.89-1.69],0.2198694778758913
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,14182,909,1.54 [1.26-1.87],1.7962759921757514e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",20013,264,1.45 [1.00-2.11],0.0474066952708609
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18871,230,1.14 [0.75-1.71],0.5396356814526353
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Angina pectoris,17452,1317,1.02 [0.86-1.22],0.7905394890393969
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18960,319,1.15 [0.81-1.62],0.4407141785386707
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18711,70,1.60 [0.81-3.17],0.1785549476659716
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18879,238,2.12 [1.52-2.97],1.152262285123698e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10283,2408,1.26 [1.10-1.43],0.0005613414585047
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,AV-block,15418,564,1.06 [0.81-1.39],0.6668869117006591
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20058,477,0.94 [0.70-1.26],0.6706075350936069
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cardiac arrest,8101,226,2.05 [1.43-2.94],8.886093386407601e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15033,179,1.21 [0.76-1.94],0.4242203706512288
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14945,91,1.54 [0.81-2.92],0.1838771080019782
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20124,63,1.49 [0.70-3.14],0.2985366578510864
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Conduction disorders,16161,1307,1.23 [1.04-1.46],0.0186142989579362
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18474,2361,1.18 [1.04-1.35],0.0092210352455879
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16309,7735,1.16 [1.08-1.25],8.444809670738413e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18787,290,1.54 [1.09-2.19],0.0151003930367622
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Endocarditis,14933,79,2.69 [1.55-4.66],0.0004185178158971
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19880,1396,1.56 [1.33-1.82],3.1941033337999566e-08
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertension,17369,6847,1.14 [1.05-1.23],0.0010333376472979
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17373,6851,1.13 [1.05-1.22],0.0016538310326609
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19983,85,4.56 [3.18-6.55],1.873928690552245e-16
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10768,246,2.51 [1.82-3.45],1.4909626316942218e-08
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10652,130,2.05 [1.28-3.26],0.0026558554056
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypotension,19975,1340,1.21 [1.02-1.44],0.0267280375714297
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19040,124,0.89 [0.50-1.58],0.682901050618524
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18629,2494,1.17 [1.03-1.32],0.0148892952034702
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19701,677,1.37 [1.08-1.72],0.0088611078171283
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Left bundle-branch block,15286,432,1.48 [1.11-1.98],0.0081922143763137
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19564,904,1.19 [0.97-1.47],0.0899674336173482
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16912,777,1.28 [1.03-1.59],0.0282525877059096
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",20018,167,1.07 [0.66-1.73],0.7982571260023006
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20091,347,1.26 [0.91-1.75],0.1679148106323392
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Oesophageal varices,18556,59,5.15 [3.43-7.74],2.9538984160319894e-15
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other aneurysm,18727,86,0.97 [0.49-1.93],0.936689928107152
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other arrhythmias,15358,504,1.34 [1.01-1.76],0.03961667503732
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18753,112,1.24 [0.70-2.21],0.4586501415320884
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18916,275,1.73 [1.23-2.44],0.0015238657762419
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15047,193,1.27 [0.81-1.98],0.295732945003463
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other disorders of veins,18586,89,1.80 [0.97-3.32],0.0611816944998606
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18536,39,0.91 [0.33-2.55],0.857099465435941
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18405,75,0.77 [0.37-1.64],0.500734143901505
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18641,144,2.35 [1.50-3.67],0.0001903626388893
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16063,1209,1.40 [1.17-1.67],0.0001787364322511
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18687,52,4.01 [2.34-6.87],4.051834777687198e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19255,614,1.26 [0.98-1.61],0.0685122375111302
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19466,469,1.94 [1.50-2.52],4.383032685492145e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19144,814,1.06 [0.85-1.33],0.5900572938924666
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8226,351,1.52 [1.10-2.12],0.0121267825209737
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19108,499,1.50 [1.15-1.96],0.0025424103800117
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18861,364,1.52 [1.11-2.08],0.0089444525224749
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19507,510,1.22 [0.93-1.61],0.1596005391347311
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,20039,820,1.69 [1.38-2.08],3.394777630897839e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Right bundle-branch block,15291,437,1.41 [1.05-1.89],0.021376732826086
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19461,464,1.98 [1.53-2.57],1.932924803955864e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18547,217,2.00 [1.36-2.93],0.0004144783973056
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19685,769,1.28 [1.03-1.60],0.0266801724709724
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19673,801,1.28 [1.03-1.59],0.0265761088812981
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19014,50,1.37 [0.58-3.23],0.4741686110434351
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18725,84,1.17 [0.60-2.30],0.6491763307983619
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19292,268,0.90 [0.61-1.33],0.5882360515612783
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18940,280,1.13 [0.78-1.63],0.5283888029358643
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Varicose veins,18931,434,1.59 [1.19-2.11],0.001491703363826
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18656,98,1.26 [0.68-2.35],0.4580535614260208
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19886,805,1.34 [1.08-1.67],0.0071879350343517
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",20058,289,0.85 [0.58-1.24],0.3889255638388155
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17301,1192,1.01 [0.84-1.21],0.9547746160824954
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Any mental disorder,19683,3574,0.99 [0.89-1.10],0.8153203855454303
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",20033,340,0.84 [0.60-1.20],0.3395546805806343
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17325,1216,1.03 [0.86-1.24],0.7276808753028721
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16173,64,0.83 [0.37-1.86],0.6587983660268495
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Smoking dependency,19692,999,1.10 [0.91-1.33],0.3416147939865782
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17349,1240,1.00 [0.83-1.19],0.9594371495437544
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Vascular dementia,19409,200,1.19 [0.77-1.84],0.4343606890124586
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Alzheimer disease,20127,511,0.80 [0.60-1.06],0.1250954584637254
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",12551,98,0.66 [0.34-1.29],0.2211584071188995
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Bell's palsy,18561,73,2.46 [1.33-4.54],0.0039652098620043
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18913,425,0.72 [0.52-0.98],0.0360989044732359
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Cerebral cysts,19756,208,1.76 [1.18-2.62],0.0051984206550914
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,20063,329,1.55 [1.12-2.15],0.0078081258174554
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19421,72,1.24 [0.60-2.56],0.5595912266281197
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20111,62,1.31 [0.60-2.84],0.4952480243354326
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19618,70,2.07 [1.08-3.98],0.0286697162231848
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Epilepsy,18859,251,1.40 [0.95-2.05],0.0877054508665974
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19740,1132,1.07 [0.89-1.29],0.4655457637267203
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20078,545,0.79 [0.60-1.04],0.0960927010092485
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19561,2888,1.07 [0.95-1.20],0.2732108236167358
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Generalized epilepsy,19816,45,3.12 [1.63-5.98],0.0005989803979816
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Hemiplegia,20003,269,1.70 [1.20-2.41],0.0031144027429901
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Hydrocephalus,19608,60,0.45 [0.19-1.04],0.0616048777970032
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20115,57,1.72 [0.80-3.68],0.1615556781611099
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18550,62,1.09 [0.49-2.42],0.8275418727793785
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18550,62,0.59 [0.26-1.36],0.2178113770840278
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Memory loss,19190,132,1.03 [0.59-1.79],0.9112782300091484
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Migraine,18847,239,1.05 [0.69-1.58],0.8250896056847099
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20084,218,1.19 [0.78-1.82],0.4178103338969541
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Motor neuron disease,12640,165,0.66 [0.40-1.11],0.1179741902954975
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,20018,52,0.91 [0.38-2.19],0.8279659830355623
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19523,1035,0.91 [0.75-1.11],0.3492897514243234
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Neurological diseases,18862,3567,0.97 [0.87-1.08],0.57997960084049
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19595,246,1.34 [0.91-1.97],0.1351486897052653
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18826,338,0.78 [0.55-1.11],0.1690132531415187
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",20058,292,1.77 [1.27-2.48],0.0008196465263273
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15272,818,1.02 [0.82-1.28],0.8611595443090866
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19617,69,1.37 [0.66-2.83],0.4009457130822313
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19681,133,0.65 [0.37-1.15],0.1381831107279567
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19715,182,0.79 [0.49-1.28],0.3386581717879644
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18568,80,2.28 [1.25-4.16],0.0072959244741529
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other headache syndromes,18654,46,1.90 [0.82-4.40],0.1339695132968129
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other neurological diseases,20033,485,1.11 [0.84-1.48],0.4698390303785094
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other sleep disorders,19035,427,0.90 [0.66-1.22],0.494943050490082
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Parkinson's disease,20096,344,0.85 [0.60-1.20],0.359430613918987
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19587,39,1.06 [0.39-2.91],0.9092689027149362
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Restless leg syndrome,20126,79,0.47 [0.22-0.98],0.0436197192584511
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Sleep apnoea,19940,368,1.02 [0.74-1.42],0.884967565634557
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19818,52,2.19 [1.07-4.46],0.0313967031786839
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20115,186,0.75 [0.47-1.21],0.2438431687004099
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18551,63,1.08 [0.49-2.39],0.8400850082059608
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20127,516,0.80 [0.60-1.06],0.1193098541506122
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19353,194,1.18 [0.76-1.84],0.4624692677595047
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19582,131,1.33 [0.78-2.25],0.2984090030727698
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19748,489,1.15 [0.87-1.53],0.3191371554105565
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19923,225,1.01 [0.67-1.53],0.958868054794472
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19062,58,0.30 [0.13-0.72],0.0070173026482361
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19040,36,2.37 [1.03-5.48],0.0429836534972902
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",20022,63,2.21 [1.13-4.30],0.0200886666343291
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19854,195,0.76 [0.48-1.21],0.2495187287590723
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2109,53,1.24 [0.55-2.82],0.60653348793378
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2593,95,1.46 [0.80-2.67],0.2195771186915126
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19544,93,0.64 [0.33-1.27],0.2036130092043269
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19892,1227,1.06 [0.88-1.27],0.5314568136038721
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19764,760,1.19 [0.95-1.49],0.1216189486162893
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19262,258,1.34 [0.92-1.96],0.125209112034474
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",20072,813,1.12 [0.90-1.39],0.3194846308368396
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20121,70,0.76 [0.35-1.65],0.4918828648805827
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,20018,759,1.11 [0.89-1.40],0.3541898830667448
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20093,434,0.88 [0.65-1.20],0.4092769411088576
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,20025,196,1.43 [0.93-2.20],0.0992150098185738
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19092,88,1.41 [0.74-2.67],0.2932887961797925
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19092,88,0.70 [0.35-1.41],0.3220556013690259
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19070,66,1.03 [0.47-2.22],0.9483296153730516
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,20009,869,1.04 [0.84-1.29],0.7188965009865692
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19378,238,0.60 [0.40-0.92],0.0200386053572818
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19319,60,0.85 [0.37-1.93],0.691033212463986
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19769,110,1.02 [0.56-1.86],0.9495552494619396
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19994,335,0.87 [0.61-1.24],0.4418045610968287
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19448,189,1.15 [0.73-1.80],0.5568055768805371
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19949,120,1.46 [0.85-2.52],0.174273195014546
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19703,563,1.28 [0.99-1.66],0.0605121308739532
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19589,138,0.93 [0.54-1.60],0.7997887277955935
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18021,2797,1.06 [0.94-1.19],0.343147096482492
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19958,299,0.88 [0.60-1.27],0.4860549217481709
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20111,164,1.13 [0.69-1.83],0.6296517949775333
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19472,468,1.04 [0.78-1.39],0.7944156451240689
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19740,81,0.76 [0.37-1.56],0.4499362392567433
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20113,62,0.59 [0.26-1.35],0.2137431309470014
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19114,110,1.03 [0.56-1.88],0.9232607655423314
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19159,155,0.89 [0.53-1.49],0.6584225895139344
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18807,142,1.29 [0.77-2.15],0.3376907967294763
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19307,48,1.30 [0.54-3.15],0.5583419773795802
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18732,67,0.57 [0.26-1.28],0.1746858502701262
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19242,102,0.74 [0.39-1.40],0.3548834712792226
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19390,250,0.95 [0.64-1.42],0.816231259083211
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19136,132,1.59 [0.96-2.65],0.0741378202005619
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18745,80,1.12 [0.55-2.28],0.7479653528974424
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18773,108,1.06 [0.58-1.96],0.8409971968467289
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17561,2337,1.05 [0.92-1.20],0.438871947576108
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19086,82,1.76 [0.95-3.29],0.0743365602694988
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19883,432,0.95 [0.70-1.29],0.7271663840205156
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19518,67,1.31 [0.62-2.75],0.4821596185305739
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19617,166,1.21 [0.75-1.95],0.4409576085594524
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19925,96,1.23 [0.66-2.32],0.5174103229926117
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20090,120,1.03 [0.58-1.84],0.9108728905612982
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,20012,100,1.19 [0.64-2.22],0.5734668139901731
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19888,59,1.15 [0.51-2.59],0.7285148038988927
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19891,62,1.12 [0.51-2.48],0.7811560229274572
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,20030,1032,0.98 [0.81-1.20],0.8741803857760004
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19780,782,1.08 [0.87-1.36],0.486859238904092
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19127,129,0.53 [0.30-0.94],0.0306219860473543
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19075,77,1.39 [0.70-2.75],0.3492347910747372
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute pharyngitis,19956,53,1.02 [0.43-2.42],0.9677451092608668
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20060,157,1.36 [0.84-2.21],0.2111110961175018
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19956,53,2.53 [1.27-5.04],0.0080548165905901
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,All influenza,17868,131,2.04 [1.26-3.30],0.0035145509259715
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17865,128,2.12 [1.32-3.42],0.0020288865902039
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12484,85,1.09 [0.55-2.18],0.7998399625024725
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Allergic rhinitis,20041,207,0.82 [0.52-1.28],0.3786755843194089
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13585,1510,1.10 [0.94-1.30],0.2459011961512894
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13890,1491,1.10 [0.93-1.29],0.2782422297074347
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19680,153,1.67 [1.05-2.66],0.0313457078384805
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17823,86,1.02 [0.52-2.03],0.9455622920966356
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Bronchiectasis,16856,441,1.67 [1.27-2.20],0.0002757854057718
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16477,62,1.24 [0.56-2.75],0.5999954486979283
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19155,2740,1.14 [1.01-1.28],0.0380387419379074
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",19066,68,1.26 [0.60-2.66],0.5417167945613015
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic sinusitis,19114,116,0.62 [0.34-1.14],0.1274195039252966
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19878,1392,1.20 [1.02-1.42],0.0303617972485415
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Deviated nasal septum,19070,72,1.17 [0.56-2.42],0.6776418282530465
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18267,5256,1.22 [1.12-1.33],4.225403828369716e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19295,297,1.21 [0.85-1.73],0.2996536204135965
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Early onset COPD,18588,102,1.57 [0.88-2.82],0.1259877250161611
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Emphysema,16794,379,1.24 [0.90-1.70],0.1928820609801802
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18979,408,1.53 [1.15-2.05],0.0039779864999714
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19897,2160,1.59 [1.40-1.80],6.304964094135319e-13
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Interstitial lung disease,19015,444,1.57 [1.19-2.07],0.001429000005737
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Later onset COPD,19665,1290,1.17 [0.99-1.40],0.0712732855559947
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20111,394,1.22 [0.90-1.67],0.201262899907239
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Nasal polyp,19084,86,0.82 [0.41-1.63],0.5648345673577331
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19884,1087,1.51 [1.26-1.81],7.435552248283981e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of pleura,19881,2302,1.54 [1.36-1.75],6.218519069921609e-12
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19655,657,0.91 [0.71-1.17],0.4728244519988946
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other pleural conditions,17634,55,2.42 [1.19-4.91],0.0142904184336578
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,20010,523,1.61 [1.25-2.08],0.0002349827853626
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,20013,1476,1.48 [1.26-1.73],9.552411473897697e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural effusion,18721,1142,1.84 [1.55-2.18],4.027318799320793e-12
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural plaque,17805,226,1.56 [1.04-2.33],0.0302512523521734
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19652,1915,1.58 [1.38-1.80],2.116122651701794e-11
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,20011,294,1.28 [0.89-1.82],0.1830822268145109
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pneumothorax,17731,152,1.50 [0.92-2.45],0.1075817673482986
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pollen allergy,20118,175,0.89 [0.54-1.44],0.62697808757184
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pulmonary oedema,19564,77,1.80 [0.93-3.47],0.0809037683011893
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12461,62,0.98 [0.43-2.23],0.9528984983382104
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19868,1071,1.51 [1.26-1.82],8.740065116887247e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,19206,208,0.82 [0.52-1.28],0.3852998494167627
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Viral pneumonia,17986,249,1.84 [1.29-2.63],0.0008291127239558
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19693,199,1.70 [1.13-2.56],0.0113668841760598
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6487,103,1.56 [0.86-2.83],0.1398251734242814
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12875,52,1.24 [0.52-2.92],0.6255168565630047
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute appendicitis,20027,112,0.79 [0.43-1.45],0.4492833450112793
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute gastritis,14073,86,1.56 [0.82-2.97],0.1752424409700907
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute pancreatitis,18397,167,1.69 [1.07-2.68],0.025830670944196
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute peritonitis,19709,93,2.00 [1.14-3.51],0.0162518386909912
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19281,51,6.81 [4.36-10.63],3.5097173114483e-17
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Barrett oesophagus,14421,434,0.92 [0.68-1.25],0.590803755262618
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18355,125,1.74 [1.02-2.96],0.0415760180848713
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19767,125,1.64 [0.97-2.76],0.0623419412374898
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholecystitis,18416,186,1.27 [0.80-2.00],0.3061953772733729
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholelithiasis,19128,898,1.62 [1.33-1.97],2.123020335739817e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic gastritis,14282,295,1.00 [0.69-1.44],0.9792881969481448
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18276,46,2.11 [0.93-4.78],0.0748801047560563
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",20007,109,5.09 [3.75-6.91],2.2621737474103878e-25
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Coeliac disease,18643,106,2.23 [1.35-3.71],0.0018740934905585
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Collagenous colitis,18613,89,1.41 [0.75-2.67],0.28772670643206
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,20025,147,1.34 [0.81-2.21],0.2507666525519441
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Constipation,19882,1778,1.04 [0.89-1.21],0.6253530110868547
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn disease,18594,70,2.08 [1.10-3.92],0.0242114523301612
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19823,55,1.86 [0.88-3.94],0.1025919864475754
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18588,64,2.08 [1.07-4.04],0.0298031494372221
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Dental caries,19589,162,0.93 [0.56-1.53],0.7718549714101905
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17435,2200,1.07 [0.93-1.22],0.3258930877385046
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of appendix,20052,137,0.69 [0.40-1.21],0.1966938334161296
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of liver,20029,799,2.22 [1.84-2.69],2.238473711164792e-16
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17935,3948,1.11 [1.00-1.22],0.0506948156365939
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19835,408,1.09 [0.80-1.49],0.5684816394519834
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of peritoneum,20052,436,1.10 [0.81-1.48],0.5532607456953501
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19508,81,1.06 [0.53-2.13],0.8664872978375395
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19400,47,1.10 [0.44-2.74],0.8416993852518633
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19849,1312,1.37 [1.16-1.62],0.0002235098226926
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of tongue,19410,81,1.30 [0.66-2.59],0.4480853090025232
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19534,1304,1.64 [1.39-1.93],2.93939181016998e-09
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16089,3266,0.92 [0.82-1.03],0.1460504567273746
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Duodenal ulcer,14192,205,1.68 [1.12-2.53],0.0120600775227837
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",20038,166,1.59 [1.00-2.51],0.0479500289276018
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20098,19,0.70 [0.16-3.11],0.63555118348743
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19358,128,5.22 [3.81-7.16],1.131235362097829e-24
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12921,98,1.38 [0.75-2.55],0.2970931249351158
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Functional dyspepsia,14472,485,1.03 [0.78-1.38],0.817227013700508
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastric ulcer,14352,365,1.43 [1.04-1.96],0.0271968745197373
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16277,2290,1.05 [0.92-1.20],0.4445981344291482
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14537,550,1.37 [1.06-1.78],0.0162058050958016
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14613,7124,1.08 [1.00-1.17],0.0433532928913417
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,GI-bleeding,19615,1078,1.32 [1.10-1.59],0.0033913959118094
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19472,45,1.05 [0.41-2.67],0.917857587064429
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13679,1021,0.89 [0.73-1.09],0.271636692651138
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19290,60,3.68 [2.09-6.47],5.85879929800019e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Hernia,18357,3122,1.03 [0.92-1.15],0.6498973001844266
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Impacted teeth,20100,18,0.78 [0.17-3.59],0.745524270768647
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Impaction of intestines,12889,66,1.06 [0.49-2.31],0.8858485329271965
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Inguinal hernia,16177,942,1.00 [0.81-1.24],0.9771379601104926
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15337,102,0.55 [0.29-1.06],0.0743229401656298
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12920,97,0.92 [0.48-1.76],0.810087312197902
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18661,124,1.88 [1.13-3.11],0.0145919073108112
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,13264,441,0.92 [0.68-1.25],0.6085215473133433
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20106,283,1.93 [1.38-2.71],0.0001215266412902
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19203,679,1.64 [1.31-2.05],1.3466256368351955e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19468,944,1.45 [1.19-1.76],0.0002119045025813
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophageal obstruction,14172,185,1.32 [0.84-2.07],0.2311984590524065
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophagitis,14595,608,1.05 [0.82-1.36],0.6872977770072022
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20076,116,1.66 [0.97-2.84],0.0635677233102747
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15305,70,1.18 [0.56-2.52],0.6627169903742949
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,14014,1191,1.02 [0.85-1.23],0.8298625087047736
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18534,304,1.25 [0.87-1.79],0.2236049752050254
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18356,126,1.62 [0.95-2.75],0.0739875524521412
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestine,14490,1667,1.09 [0.94-1.27],0.2643020242839418
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestines,18131,5308,1.01 [0.92-1.10],0.8956155106383683
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19380,186,1.81 [1.19-2.76],0.0057371003463622
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of liver,19888,658,2.36 [1.92-2.90],2.1331352245015638e-16
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14653,666,1.11 [0.87-1.42],0.4024953229520515
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18409,179,1.51 [0.96-2.36],0.0732999386437649
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19987,371,1.00 [0.72-1.40],0.9776008113396102
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14928,941,1.54 [1.26-1.87],1.5254288355318894e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19627,1090,1.33 [1.11-1.60],0.0021913436830531
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19577,150,1.02 [0.61-1.70],0.9538826738459932
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14640,1817,1.05 [0.91-1.21],0.5270116079859978
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15855,1868,1.19 [1.03-1.37],0.0195625947813842
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19328,98,3.80 [2.45-5.89],2.496630916176541e-09
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19362,838,1.56 [1.27-1.91],2.063535677765936e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",13201,378,1.19 [0.86-1.63],0.2906601301533604
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20095,23,0.78 [0.20-3.01],0.714788297656482
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13350,527,1.16 [0.89-1.53],0.2677070660905424
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18681,144,1.61 [1.00-2.61],0.0521623766397254
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Recurring oral aphthae,20115,46,2.38 [1.10-5.13],0.026801997191005
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19422,88,1.73 [0.93-3.22],0.0863140886341875
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Toxic colitis,18596,72,2.02 [1.06-3.83],0.0315730117237546
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,14288,301,0.95 [0.66-1.37],0.7763089730622589
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcerative colitis,18666,142,0.91 [0.53-1.56],0.7330916853656264
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18638,114,0.91 [0.50-1.65],0.7472537841211193
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Umbilical hernia,15459,224,0.79 [0.51-1.22],0.2835877708224748
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,13031,208,1.28 [0.84-1.95],0.2541700580600876
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ventral hernia,15469,234,1.49 [1.00-2.23],0.0492960332603743
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Volvulus,12901,78,1.04 [0.51-2.12],0.9160830726833036
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,20037,354,1.01 [0.72-1.41],0.9668988436971068
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19815,62,2.10 [1.03-4.26],0.0407251108988566
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17965,143,1.10 [0.65-1.87],0.7280540467128105
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19593,708,1.62 [1.30-2.02],2.248311136184544e-05
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",19008,123,1.11 [0.63-1.95],0.7169604976356587
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18329,507,1.42 [1.08-1.85],0.0108169742827283
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19825,269,1.28 [0.88-1.86],0.1952791461023477
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,20030,474,1.21 [0.91-1.61],0.1886800264334613
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19601,45,1.12 [0.44-2.86],0.8149903818776334
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18742,3189,1.13 [1.01-1.26],0.0356223773653504
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19750,377,1.09 [0.79-1.51],0.5941514378722847
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19634,261,1.10 [0.75-1.63],0.613503940904016
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19798,913,1.49 [1.22-1.82],8.245465559701013e-05
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20110,52,1.22 [0.52-2.85],0.649787623607042
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17877,55,1.58 [0.71-3.55],0.2645179864125812
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19428,55,0.95 [0.41-2.24],0.9137840180884174
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19813,257,1.24 [0.85-1.82],0.2675171985234564
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18341,519,1.07 [0.81-1.41],0.6335198142046755
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17901,79,0.85 [0.41-1.76],0.6686164919236339
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,20053,74,1.57 [0.79-3.14],0.2018864982791231
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,19067,182,1.94 [1.28-2.94],0.0018998013349848
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19950,197,1.26 [0.82-1.95],0.2986976853628385
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19631,75,0.99 [0.48-2.07],0.9803639669788664
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17886,64,0.78 [0.35-1.75],0.5444629897438569
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19595,1773,1.18 [1.02-1.37],0.0246856895027244
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18377,555,1.11 [0.85-1.45],0.4475805675863072
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17904,82,0.86 [0.42-1.75],0.6732706026919458
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,20050,297,1.24 [0.87-1.77],0.2381215780026254
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19622,66,1.43 [0.68-3.00],0.3505695506465963
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19997,244,1.30 [0.88-1.92],0.1872685469073373
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20066,383,1.02 [0.74-1.41],0.9162965644819576
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17929,107,1.01 [0.54-1.87],0.9826198399153384
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18106,284,0.80 [0.54-1.17],0.2434879926724652
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,20054,371,1.04 [0.75-1.44],0.8166306251513729
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18093,271,2.15 [1.55-2.99],5.093938156022551e-06
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20103,124,1.51 [0.88-2.58],0.1343477570274358
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16802,68,1.00 [0.47-2.15],0.9925787833449552
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17755,5553,1.10 [1.01-1.20],0.0243977320702043
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16534,4332,1.05 [0.96-1.16],0.2837921326457905
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16780,46,1.34 [0.54-3.33],0.525655004677529
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16779,118,0.68 [0.37-1.25],0.2161772611741466
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16821,160,1.04 [0.63-1.71],0.8900143663247553
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19905,50,1.30 [0.54-3.09],0.5586859482130102
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16787,126,0.63 [0.35-1.14],0.1270414024621836
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13486,1284,1.02 [0.85-1.23],0.8063864459699557
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19939,214,0.90 [0.58-1.39],0.620856439726928
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17139,478,0.89 [0.66-1.19],0.4247822628884113
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16305,6944,1.09 [1.01-1.18],0.0229730521183746
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17963,106,0.67 [0.36-1.27],0.2180059006469516
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16887,153,1.11 [0.67-1.84],0.6899886161227169
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17179,445,1.00 [0.74-1.36],0.9841658443671916
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19310,2649,0.98 [0.87-1.11],0.7613177647262017
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17009,275,0.93 [0.63-1.37],0.7101968354378737
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16861,127,0.54 [0.30-0.96],0.0364967835504941
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16838,104,0.96 [0.51-1.80],0.8930641350418693
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19458,88,1.49 [0.79-2.83],0.2187969425668572
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13939,1737,0.98 [0.84-1.14],0.79933775605502
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12861,659,1.42 [1.12-1.81],0.0040253884763765
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",20044,653,1.34 [1.06-1.70],0.0161215584381718
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,12265,63,0.51 [0.22-1.17],0.1122507695776011
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12472,270,0.81 [0.54-1.20],0.2946430080829183
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16960,226,1.22 [0.81-1.85],0.3373195949564147
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12622,420,0.90 [0.65-1.23],0.5031923718380482
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16729,68,1.72 [0.85-3.49],0.1304290929941126
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17232,571,0.94 [0.72-1.23],0.6747010868105561
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16916,255,0.69 [0.46-1.05],0.0810028022199452
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12596,394,0.87 [0.63-1.21],0.4208255559839395
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16795,61,1.08 [0.48-2.42],0.8463981193121151
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16782,48,2.45 [1.19-5.03],0.014846412046449
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17925,68,2.89 [1.56-5.34],0.0007268799508939
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19757,1900,1.16 [1.00-1.34],0.0443570560959847
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19199,1342,1.14 [0.96-1.35],0.1405535142008503
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19983,469,1.39 [1.05-1.84],0.0202883427296829
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14895,2693,1.17 [1.04-1.33],0.0096729294733326
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,12242,40,0.69 [0.24-1.97],0.4920252238490576
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16821,87,1.26 [0.65-2.46],0.4922496584249626
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,12267,65,1.41 [0.65-3.06],0.3862122478928472
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12320,118,0.75 [0.41-1.37],0.3449608132305107
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,18062,205,0.85 [0.54-1.34],0.4891896575366873
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,18273,416,1.19 [0.88-1.62],0.2646813322132778
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20110,92,1.17 [0.61-2.24],0.6394024891311032
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18327,1666,0.97 [0.83-1.14],0.7207290804526956
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16795,61,0.77 [0.34-1.76],0.535855484238464
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12333,131,0.64 [0.36-1.13],0.124115357086727
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17324,663,0.88 [0.68-1.13],0.2994718737956325
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,14082,1880,0.96 [0.83-1.12],0.6293110700787379
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19478,108,1.58 [0.90-2.78],0.1131668102859178
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20120,59,1.96 [0.94-4.10],0.0725528146505858
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16801,67,0.92 [0.42-2.00],0.8321995070179695
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17874,1140,1.29 [1.08-1.55],0.0058573953095059
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16823,89,1.50 [0.80-2.82],0.2097249173388244
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13992,1790,1.07 [0.92-1.25],0.3588801111053367
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17961,104,0.54 [0.28-1.03],0.0622517985620449
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16763,29,1.31 [0.41-4.15],0.6502080419311622
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16829,168,0.74 [0.45-1.22],0.2373997872052449
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17308,574,1.58 [1.23-2.02],0.0002928090069068
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19801,431,1.17 [0.86-1.58],0.3143057463469159
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17210,549,1.28 [0.98-1.66],0.0707139407137071
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19994,464,1.45 [1.10-1.92],0.0087813537440256
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20105,58,1.20 [0.54-2.67],0.6587516199948582
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16874,140,0.95 [0.55-1.64],0.8581372659054906
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15700,739,1.15 [0.91-1.45],0.2282949382635691
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17273,539,1.11 [0.85-1.45],0.4465238739722532
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16982,248,0.90 [0.59-1.35],0.5969990947897474
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",12266,64,0.70 [0.31-1.58],0.3887539211689186
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14889,2687,1.18 [1.04-1.33],0.0086535278403717
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12915,713,1.05 [0.83-1.34],0.6813212885125337
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19692,322,0.69 [0.48-1.00],0.0492042314259975
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20081,63,1.08 [0.49-2.39],0.8459284511888125
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17834,59,0.68 [0.30-1.57],0.3706746220179088
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,12262,60,1.98 [0.93-4.19],0.075079789804091
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16754,93,0.97 [0.50-1.89],0.930728012640632
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12678,476,1.42 [1.07-1.90],0.0157682549764513
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17024,290,0.90 [0.62-1.31],0.5757443919987684
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16902,241,0.86 [0.57-1.31],0.4848638533151905
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16880,219,0.87 [0.56-1.34],0.5317578961968283
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,14193,60,2.18 [1.08-4.40],0.0293107590127943
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20109,62,1.15 [0.53-2.52],0.7217999545716867
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17208,474,0.95 [0.71-1.28],0.7402994651601694
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19457,87,3.12 [1.97-4.93],1.131358527941911e-06
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18993,2259,1.18 [1.04-1.35],0.0121429940440454
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16862,128,1.50 [0.88-2.57],0.1389598735910721
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17239,578,0.99 [0.76-1.29],0.9562708529631382
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18927,230,0.78 [0.51-1.20],0.2653304162217138
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16859,198,0.79 [0.50-1.25],0.3129516102359965
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18326,1665,0.93 [0.79-1.09],0.360024348416281
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17748,1087,0.89 [0.73-1.08],0.2337816574415249
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16783,49,0.80 [0.32-2.03],0.6415541600685213
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19477,107,3.30 [2.19-4.98],1.3638992330811996e-08
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16883,149,1.22 [0.73-2.03],0.4455741903438339
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16815,81,1.98 [1.05-3.75],0.0361160095377849
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),12265,63,1.12 [0.50-2.53],0.7763536636824222
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18976,1834,1.76 [1.54-2.01],1.6962637987720359e-16
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),8122,23,0.75 [0.20-2.91],0.6826189420829037
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10300,27,0.56 [0.16-1.96],0.3634128816063713
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19848,265,1.11 [0.76-1.63],0.5967050528362057
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19673,90,0.97 [0.49-1.90],0.9228741608374158
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18905,1763,1.55 [1.34-1.79],2.354663515570368e-09
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19943,89,2.43 [1.41-4.18],0.0012991892039322
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19896,340,1.69 [1.23-2.31],0.0011443100898658
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Cystitis,16897,262,1.36 [0.93-1.99],0.1119529974542843
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Dialysis,17213,71,1.65 [0.81-3.35],0.1653357911707342
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8812,1828,0.99 [0.85-1.15],0.8799939810268327
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10382,109,0.92 [0.50-1.69],0.7780535625275582
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Endometriosis,8134,35,0.99 [0.34-2.91],0.984490830540092
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8593,494,0.95 [0.71-1.26],0.7079667334064195
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16629,5329,1.18 [1.08-1.28],0.0001967413849624
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19922,68,2.12 [1.10-4.10],0.0257691928085328
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hydrocele,7087,103,0.52 [0.27-1.01],0.0546070154662985
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17170,282,1.03 [0.71-1.51],0.8594318554711926
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8540,1556,1.03 [0.87-1.21],0.7469045087983573
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10438,138,1.42 [0.85-2.39],0.1822828437221743
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),7090,106,0.76 [0.40-1.43],0.3922456539674798
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16706,71,1.25 [0.60-2.61],0.5516080449786915
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8987,888,1.08 [0.87-1.33],0.4901566039620617
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,7036,52,0.89 [0.36-2.20],0.8075161826424436
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,8133,34,2.59 [0.98-6.84],0.0551587655928975
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20121,75,1.11 [0.54-2.29],0.7709634541717082
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20117,75,1.25 [0.61-2.54],0.5404508689733533
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19100,2465,1.18 [1.04-1.34],0.0088214875277154
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17445,810,0.93 [0.74-1.17],0.547183429916379
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10319,46,1.41 [0.58-3.46],0.4484906548122319
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20064,508,1.66 [1.28-2.15],0.000121489450761
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,7107,123,1.41 [0.82-2.43],0.2173374375159671
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,7122,138,0.84 [0.48-1.45],0.5244977541803124
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,7111,127,0.73 [0.41-1.30],0.2866062248322656
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20096,70,1.46 [0.72-2.98],0.2987945718031257
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18557,1922,1.26 [1.09-1.45],0.0014823531207698
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10373,73,1.25 [0.60-2.57],0.5528815673175186
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,8163,64,1.09 [0.49-2.39],0.8338321925111221
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8234,135,1.07 [0.62-1.85],0.7962092557145353
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,8149,50,0.85 [0.34-2.09],0.7160450308947884
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,8186,87,0.53 [0.26-1.07],0.0777861639546542
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17220,332,1.13 [0.80-1.60],0.4893013380546338
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19720,164,1.43 [0.89-2.31],0.1379150855654209
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,8205,106,1.58 [0.88-2.85],0.1261799740509348
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,8120,21,0.83 [0.20-3.41],0.798809862019162
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8287,188,0.91 [0.57-1.45],0.698590514651692
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,8181,82,0.73 [0.36-1.50],0.3977933234219685
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8281,182,0.94 [0.58-1.50],0.7814785245774979
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19902,48,1.61 [0.68-3.79],0.2746765578127758
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",7113,129,1.63 [0.98-2.71],0.0613144235582682
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19916,3028,1.53 [1.37-1.71],1.2958368088627651e-14
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16965,77,2.26 [1.23-4.15],0.0088477756470636
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17284,142,2.35 [1.50-3.68],0.0002039874243489
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19617,34,0.55 [0.18-1.70],0.3002073448155131
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16864,229,1.37 [0.91-2.05],0.1265795644621956
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19924,341,1.06 [0.75-1.49],0.7427516929327393
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Uterine polyps,8132,33,0.80 [0.26-2.44],0.6976778660633298
